Abstract
Background
To analyze the influence of tumor location, including tumor adjacency and located segments on long-term survival outcomes for patients with solitary hepatocellular carcinoma (HCC) after microwave ablation (MWA).
Methods
This retrospective study evaluated 850 patients. The hepatic segments where the tumor is located, tumor adjacency (important tissues adjacent to tumor) and other clinical characteristics were collected. Overall survival (OS), local tumor progression (LTP) and disease-free survival (DFS) were compared and analyzed. Influence of tumor location was evaluated by multi-models and the effect of adjacency for OS, LTP, and DFS in different segments was analyzed by stratification analysis.
Results
The OS, LTP, and DFS rates were similar in different hepatic segments, so were in high risk and safe locations. In multi-models, HCC in segment 8 showed lower death rate of 43% than that in segment 2 (HR 0.57; P = 0.01) and tumors in segment 6 seemed to have lower LTP rate. Tumors in high-risk locations were risk factors for OS, LTP, and DFS compared with tumors in safe locations, but all differences were not significant in different models. The effects of tumor adjacency on survival outcomes among subgroups of segments were limited.
Conclusion
The tumor adjacency was not a prognostic factor of survival outcomes for patients with solitary tumors after MWA, but tumors in segment 8 seemed to better OS rate than tumors in other segments.
Similar content being viewed by others
References
Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-1462.
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017;389:56-66.
El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492-2502.
Liang P, Yu J, Lu MD, Dong BW, Yu XL, Zhou XD, Hu B, et al. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol 2013;19:5430-5438.
Thamtorawat S, Hicks RM, Yu J, Siripongsakun S, Lin WC, Raman SS, McWilliams JP, et al. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? J Vasc Interv Radiol 2016;27:623-630.
Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, et al. Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation. Cancers (Basel) 2018;10.
Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 2015;21:1554-1566.
Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014;270:888-899.
Dou JP, Yu J, Yang XH, Cheng ZG, Han ZY, Liu FY, Yu XL, et al. Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score analysis. Oncotarget 2017;8:28758-28768.
Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. European Radiology 2018;29:2706-2715.
Wang X, Xue H-d, Jin Z-y, Su B-y, Li Z, Sun H, Chen Y, et al. Quantitative hepatic CT perfusion measurement: Comparison of Couinaud’s hepatic segments with dual-source 128-slice CT. European Journal of Radiology 2013;82:220-226.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 2014;273:241-260.
Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2009;20:S189-191.
Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014;30:134-141.
Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol 2012;81:1455-1459.
Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol 2019;29:2706-2715.
Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Li QY, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol 2015;25:1119-1126.
Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299-307.
Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 2017;143:131-142.
Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave Ablation (MWA): Basics, Technique and Results in Primary and Metastatic Liver Neoplasms - Review Article. Rofo 2017;189:1055-1066.
Hsieh YC, Limquiaco JL, Lin CC, Chen WT, Lin SM. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol (NY) 2019;44:1141-1151.
Li MD, Chen Y, Chen YX, Gao ZL, Zhu K, Yin X. [Whole-liver perfusion imaging by multi-slice spiral computed tomography based on Couinaud segments for evaluation of the blood flow state in patients with hepatitis B cirrhosis]. Zhonghua Gan Zang Bing Za Zhi 2014;22:817-821.
Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology 2007;243:736-743.
Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci 2017;18.
Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43.
Soliman AF, Abouelkhair MM, Hasab Allah MS, El-Kady NM, Ezzat WM, Gabr HA, Elsayed EH, et al. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis. Asian Pacific Journal of Cancer Prevention 2019;20:295-301.
Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, et al. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study. Radiology 2016;280:300-312.
Liu F, Yu X, Cheng Z, Han Z, Sun Y, Liang P, Zhou F. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma. Eur J Radiol 2017;91:93-98.
Acknowledgements
This work was supported by Grant 2017YFC0112000 and 2018ZX10723-204 from the National Key R&D Program of Ministry of Science and Technology of China, Grants 81627803,81622024 and 81801722 from the National Scientific Foundation Committee of China.
Author information
Authors and Affiliations
Contributions
PL, JY, JD: Concept and design. JD, JY: Experiments and procedures: All authors. Writing of article. JD: Statistical analysis.
Corresponding authors
Ethics declarations
Conflict of interest
All authors declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dou, Jp., Han, Zy., Cheng, Zg. et al. The effect of tumor location on long-term results of microwave ablation for early-stage hepatocellular carcinoma. Abdom Radiol 45, 3923–3933 (2020). https://doi.org/10.1007/s00261-020-02472-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02472-z